RBC Europe’s Enzo Biochem, Inc. ENZ Stock Holding History

RBC Europe’s Portfolio ENZ Stock Details ENZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-180	Closed	-$1.47K	–	1171
2017 Q4	$1.47K	Hold	180	–	–	﹤0.01%	1066
2017 Q3	$1.89K	Buy	+180	New	+$2K	﹤0.01%	1052

Other funds holding ENZ

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TCIM

TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

RBC Europe's ENZ Position: Q1 2018 in Review

RBC Europe sold out of Enzo Biochem, Inc. (ENZ) in Q1 2018, closing a stake of 180 shares — an estimated $1.47K sold.

RBC Europe first reported a position in ENZ in Q3 2017 and held it in 2 quarters. The position peaked at $1.89K in Q3 2017. 107 funds tracked by Wall St. Rank hold ENZ as of Q1 2018.

RBC Europe reported no remaining Enzo Biochem, Inc. position as of Q1 2018 after selling out during the quarter.
RBC Europe sold 180 Enzo Biochem, Inc. shares in Q1 2018, an estimated $1.47K.
RBC Europe first reported a position in Enzo Biochem, Inc. in Q3 2017 and held it in 2 quarters.
RBC Europe's Enzo Biochem, Inc. position peaked at $1.89K in Q3 2017.
107 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q1 2018.

Based on RBC Europe's 13F filing for Q1 2018, filed 9 Nov 2023.